Inhibitory effects of daidzein on intestinal motility in normal and high contractile states

Pharmaceutical Biology

Volumn 50, Issue 12, 2012, Pages 1561-1566

  Chen, Dapeng ^a   Xiong, Yongjian ^a   Tang, Zeyao ^a   Lv, Bochao ^a   Lin, Yuan ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Adrenergic and effects; Intestinal contractility; Myosin phosphorylation

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CALCIUM ION; DAIDZEIN; ERYTHROMYCIN; HISTAMINE; MYOSIN; MYOSIN LIGHT CHAIN KINASE; N(G) NITROARGININE; NITRIC OXIDE; PHENTOLAMINE; PROPRANOLOL; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; INTESTINE CONTRACTION; INTESTINE MOTILITY; JEJUNUM; MOUSE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION;

ANIMALS; CA(2+) MG(2+)-ATPASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; ISOFLAVONES; JEJUNUM; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYOSINS; NITRIC OXIDE; PHOSPHORYLATION; PHYTOESTROGENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84869410097     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2012.698285     Document Type: Article

References (22)

1. Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72, 248-254.
2. Dwiecki K, Neunert G, Polewski P, Polewski K. (2009). Antioxidant activity of daidzein, a natural antioxidant, and its spectroscopic properties in organic solvents and phosphatidylcholine liposomes. J Photochem Photobiol B, Biol, 96, 242-248.
3. Goldstein AM, Nagy N. (2008). A bird's eye view of enteric nervous system development: Lessons from the avian embryo. Pediatr Res, 64, 326-333.
4. Gottstein N, Ewins BA, Eccleston C, Hubbard GP, Kavanagh IC, Minihane AM, Weinberg PD, Rimbach G. (2003). Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. Br J Nutr, 89, 607-616.
5. Harnish DC, Albert LM, Leathurby Y, Eckert AM, Ciarletta A, Kasaian M, Keith JC Jr. (2004). Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol, 286, G118-G125. (Pubitemid 38055845)
6. Kase Y, Hayakawa T, Takeda S, Ishige A, Aburada M, Okada M. (1996). Pharmacological studies on antidiarrheal effects of Hangeshashin-to. Biol Pharm Bull, 19, 1367-1370. (Pubitemid 26363637)
7. Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. (2007). Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev, CD001395.
8. Li M, Johnson CP, Adams MB, Sarna SK. (2002). Cholinergic and nitrergic regulation of in vivo giant migrating contractions in rat colon. Am J Physiol Gastrointest Liver Physiol, 283, G544-G552. (Pubitemid 34920340)
9. Lin GM, Xu ZL, Zhang X, Gao H, Hou Y, Yin LB, Zhang XD, Yang JX, Jia TZ. (2011). Epoxyaurapten inhibition of smooth muscle contraction and phosphorylation of myosin light chain by myosin light chain kinase. J Med Plants Res, 5, 3412-3420.
10. Lin Y, Sun H, Dai S, Tang Z, He X, Chen H. (2000). The bi-directional regulation of filamin on the ATPase activity of smooth muscle myosin. Chin Med Sci J, 15, 162-164.
11. Mang CF, Truempler S, Erbelding D, Kilbinger H. (2002). Modulation by NO of acetylcholine release in the ileum of wild-type and NOS gene knockout mice. Am J Physiol Gastrointest Liver Physiol, 283, G1132-G1138. (Pubitemid 35192850)
12. Mathison R, Shaffer E. (2006). Increased cholinergic contractions of jejunal smooth muscle caused by a high cholesterol diet are prevented by the 5-HT4 agonist-tegaserod. BMC Gastroenterol, 6, 8.
13. McCue P, Shetty K. (2004). Health benefits of soy isoflavonoids and strategies for enhancement: A review. Crit Rev Food Sci Nutr, 44, 361-367. (Pubitemid 39357993)
14. Park OJ, Surh YJ. (2004). Chemopreventive potential of epigallocatechin gallate and genistein: Evidence from epidemiological and laboratory studies. Toxicol Lett, 150, 43-56. (Pubitemid 38447236)
15. Sarkar FH, Li Y. (2003). Soy isoflavones and cancer prevention. Cancer Invest, 21, 744-757. (Pubitemid 37377330)
16. Schemann M. (2005). Control of gastrointestinal motility by the "gut brain"-the enteric nervous system. J Pediatr Gastroenterol Nutr, 41 Suppl 1, S4-S6. (Pubitemid 41291429)
17. Setchell KD, Cassidy A. (1999). Dietary isoflavones: Biological effects and relevance to human health. J Nutr, 129, 758S-767S.
18. Tang Z, Chen H, Yang J, Dai S, Lin Y. (2005). The comparison of Ca2+/CaM-independent and Ca2+/CaM-dependent phosphorylation of myosin light chains by MLCK. Physiol Res, 54, 671-678. (Pubitemid 43161734)
19. Torregrosa G, Burguete MC, Pérez-Asensio FJ, Salom JB, Gil JV, Alborch E. (2003). Pharmacological profile of phytoestrogens in cerebral vessels: in vitro study with rabbit basilar artery. Eur J Pharmacol, 482, 227-234. (Pubitemid 37505949)
20. Toyomura K, Kono S. (2002). Soybeans, soy foods, isoflavones and risk of colorectal cancer: A review of experimental and epidemiological data. Asian Pac J Cancer Prev, 3, 125-132.
21. Valachovicova T, Slivova V, Sliva D. (2004). Cellular and physiological effects of soy flavonoids. Mini Rev Med Chem, 4, 881-887. (Pubitemid 39200075)
22. Yang JX, Wang XM, Tang ZY, Chen H, Xu H, Lin Y. (2003). The characterization of Ca(2+)-calmodulin independent phosphorylation of myosin light chains by a fragment from myosin light chain kinase. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao, 35, 793-800. (Pubitemid 38056514)